Risk stratification of net adverse clinical events using CHADS-P2A2RC and CHADS2 scores in chronic coronary syndrome patients without atrial fibrillation: Insights from the CLIDAS-PCI
Open Access
- 4 June 2025
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 437, 133464
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Strategic Promotion of Innovative R and D (JPJ012425)
- Kowa Company
- Società Italiana di Pediatria
This publication has 30 references indexed in Scilit:
- Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary InterventionJACC, 2023
- Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular diseaseInternational Journal of Cardiology, 2021
- Impact of high-dose statin on cardiovascular outcomes in real-world patients with ST-elevation acute myocardial infarctionHeart and Vessels, 2020
- A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial FibrillationThe American Journal of Cardiology, 2020
- Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studiesInternational Journal of Cardiology, 2017
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting StentsJACC, 2016
- Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary InterventionJAMA, 2016
- Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary InterventionJACC, 2015
- A Comparison of the Clinical Impact of Bleeding Measured by Two Different Classifications Among Patients With Acute Coronary SyndromesJACC, 2006
- Validation of Clinical Classification Schemes for Predicting StrokeJAMA, 2001